Recombinant Human PCAF Protein，GST

PCAF (p300/CBP-associated factor) is a crucial histone acetyltransferase involved in the regulation of gene expression through chromatin remodeling. First identified as a coactivator of nuclear hormone receptors, PCAF plays a significant role in numerous cellular processes, including proliferation, differentiation, and apoptosis. Its dysfunction is linked to various diseases, including cancer and neurodegenerative disorders. Research into PCAF has gained momentum due to its dual function as both a transcriptional coactivator and a regulator of histone acetylation, making it a potential target for therapeutic intervention. The complexity of its interaction with other transcription factors and chromatin remodeling complexes complicates the understanding of its precise mechanisms. Recent studies have focused on the structural characterization of PCAF and the development of small molecules that can modulate its activity. Advanced techniques such as cryo-electron microscopy and X-ray crystallography have provided insights into PCAF’s structure-function relationships, highlighting potential sites for targeted drug design. Furthermore, research emphasizes the need to explore PCAF’s role in different cellular contexts, including stem cell biology and immune response, to fully unravel its biological significance. As therapeutic strategies increasingly incorporate epigenetic modulators, elucidating the role of PCAF and its pathways could pave the way for novel treatments in cancer and other diseases associated with epigenetic dysregulation.